Acorda Therapeutics Inc (NASDAQ:ACOR)

2.71
BATS BZX Real-Time Price
As of 3:34pm ET
 +0.01 / +0.37%
Today’s Change
2.34
Today|||52-Week Range
8.66
-34.55%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +269.00% increase from the last price of 2.71.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.11
Sales
$31.0M
Reporting Date
Feb 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 54.32%
 
 
 
 
 
 
Growthannually 37.99%
 
 
 
 
 
 

Sales

Growthquarterly -1.42%
 
 
 
 
 
 
Growthannually -21.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.